Get the Stockscreener App
1.35
2.17%
-0.03
After Hours:
1.34
-0.01
-0.74%
Artelo Biosciences Inc Stock (ARTL) Forecast
The Artelo Biosciences Inc (ARTL) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $38.10, representing a +2,722% increase from the current price of $1.35. The highest analyst price target is $75.20, and the lowest is $1.0006.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ARTL Price Target
Average 38.10
(+2,722% Upside)
Is Artelo Biosciences Inc (ARTL) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 44.45 | Neutral |
| STOCH(9,6) | 59.86 | Neutral |
| STOCHRSI(14) | 83.85 | Sell |
| MACD(12,26) | -0.0398 | Buy |
| ADX(14) | 31.50 | Sell |
| William %R | -56.52 | Neutral |
| CCI(14) | 24.81 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.3368
Buy
|
1.3537
Sell
|
| MA20 |
1.3996
Sell
|
1.3838
Sell
|
| MA50 |
1.4593
Sell
|
1.431
Sell
|
| MA100 |
1.449
Sell
|
1.4639
Sell
|
| MA200 |
1.5231
Sell
|
1.624
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, ARTL could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 11 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on ARTL, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 44.45 indicates that ARTL is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 59.86 indicates that ARTL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 83.85 indicates that ARTL is oversold. This suggests that ARTL price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 31.5 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 24.81 indicates that ARTL is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term ARTL price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Artelo Biosciences Inc financial reports and earnings history, Artelo Biosciences Inc (ARTL) stock could reach $1.901 by 2030, $3.5857 by 2040 and $8.1336 by 2050. See the projected annual prices until 2050 of the Artelo Biosciences Inc stock below:
- Artelo Biosciences Inc (ARTL) is expected to reach an average price of $1.7458 in 2035, with a high prediction of $1.9653 and a low estimate of $1.6158. This indicates an $29.32% rise from the last recorded price of $1.35.
- Artelo Biosciences Inc (ARTL) stock is projected to chart a bullish course in 2040, with an average price target of $2.3161, representing an $71.56% surge from its current level. The forecast ranges from a conservative $2.0761 to a sky-high $3.5857.
- Our analysts predict Artelo Biosciences Inc (ARTL) to jump 220.63% by 2045, soaring from $4.0075 to an average price of $4.3285, potentially reaching $5.217. While $4.0075 is the low estimate, the potential upside is significant.
- Artelo Biosciences Inc (ARTL) stock is expected to climb by 2050, reaching an average of $6.7322, a $398.68% jump from its current level. However, a wide range of estimates exists, with high and low targets of $8.1336 and $6.709, respectively, highlighting the market's uncertainty.
Artelo Biosciences Inc Stock (ARTL) Year by Year Forecast
Artelo Biosciences Inc Stock (ARTL) Price Forecast for 2024
Our forecast for ARTL stock price in 2024 now indicates an average price target of $38.10 with a high forecast of $75.20 and a low forecast of $1.0001. The average prediction reflects an increase of +2,722% from the last recorded price of $1.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $69.20 | $1.0006 | $75.20 | +5,026% |
| July, 2024 | $49.55 | $41.45 | $75.05 | +3,570% |
| August, 2024 | $30.20 | $2.922 | $52.55 | +2,137% |
| September, 2024 | $33.20 | $26.60 | $40.40 | +2,359% |
| October, 2024 | $35.75 | $23.50 | $39.20 | +2,548% |
| November, 2024 | $33.70 | $27.35 | $39.44 | +2,397% |
| December, 2024 | $39.95 | $30.35 | $44.75 | +2,860% |
Artelo Biosciences Inc Stock (ARTL) Price Forecast for 2025
Artelo Biosciences Inc Stock (ARTL) is expected to reach an average price of $33.84 in 2025, with a high prediction of $66.56 and a low estimate of $1.1176. This indicates an +2,406% rise from the last recorded price of $1.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $39.35 | $2.8847 | $46.40 | +2,815% |
| February, 2025 | $30.66 | $2.4651 | $43.33 | +2,171% |
| March, 2025 | $16.26 | $1.5256 | $66.56 | +1,104% |
| April, 2025 | $14.61 | $9.3561 | $30.96 | +981.95% |
| May, 2025 | $17.91 | $1.1176 | $29.91 | +1,226% |
| June, 2025 | $18.21 | $15.66 | $23.91 | +1,249% |
| July, 2025 | $22.71 | $16.41 | $26.46 | +1,582% |
| August, 2025 | $18.88 | $16.41 | $25.86 | +1,299% |
| September, 2025 | $18.96 | $16.41 | $20.46 | +1,304% |
| October, 2025 | $11.31 | $9.3895 | $21.38 | +737.74% |
| November, 2025 | $15.10 | $10.41 | $19.71 | +1,018% |
| December, 2025 | $7.0776 | $7.0356 | $22.71 | +424.27% |
Artelo Biosciences Inc Stock (ARTL) Price Forecast for 2026
The predicted value for Artelo Biosciences Inc (ARTL) in 2026 is set at an average of $31.12. Estimates vary from a peak of $55.26 to a trough of $6.9758, indicating an +2,205% surge from the present price of $1.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $9.2111 | $6.9758 | $11.46 | +582.31% |
| February, 2026 | $9.2941 | $8.2813 | $11.01 | +588.45% |
| March, 2026 | $14.76 | $8.9943 | $18.81 | +993.38% |
| April, 2026 | $36.06 | $13.41 | $55.26 | +2,571% |
| May, 2026 | $30.81 | $19.56 | $39.21 | +2,182% |
| June, 2026 | $23.01 | $22.71 | $31.71 | +1,605% |
| July, 2026 | $16.86 | $15.96 | $23.31 | +1,149% |
| August, 2026 | $18.66 | $17.01 | $20.16 | +1,283% |
| September, 2026 | $17.02 | $14.77 | $19.54 | +1,160% |
| October, 2026 | $14.47 | $13.93 | $17.47 | +971.77% |
| November, 2026 | $13.88 | $11.92 | $15.13 | +928.14% |
| December, 2026 | $12.07 | $11.92 | $14.77 | +794.41% |
Artelo Biosciences Inc Stock (ARTL) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Artelo Biosciences Inc (ARTL) is $11.93, with a high forecast of $20.02 and a low forecast of $3.8333. This indicates an +783.37% increase from the last price of $1.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $11.32 | $10.90 | $12.37 | +738.23% |
| February, 2027 | $11.80 | $10.57 | $20.02 | +774.26% |
| March, 2027 | $8.9937 | $8.1776 | $11.77 | +566.20% |
| April, 2027 | $6.8192 | $6.3692 | $9.5189 | +405.12% |
| May, 2027 | $6.3697 | $5.4694 | $6.8197 | +371.83% |
| June, 2027 | $6.0763 | $5.32 | $7.2525 | +350.10% |
| July, 2027 | $6.9708 | $5.8274 | $8.0867 | +416.35% |
| August, 2027 | $5.7368 | $5.5208 | $11.30 | +324.95% |
| September, 2027 | $5.3894 | $4.7216 | $6.5214 | +299.21% |
| October, 2027 | $4.9129 | $4.7374 | $6.1698 | +263.92% |
| November, 2027 | $5.1744 | $4.4316 | $5.6181 | +283.29% |
| December, 2027 | $4.0135 | $3.8333 | $6.0735 | +197.30% |
Artelo Biosciences Inc Stock (ARTL) Price Forecast for 2028
In 2028, Artelo Biosciences Inc (ARTL) is projected to reach an average price of $4.5212, with a high projection of $7.4236 and a low estimate of $1.6187. This indicates an +234.90% rise from the last price of $1.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $4.114 | $3.8686 | $7.4236 | +204.74% |
| February, 2028 | $3.6745 | $3.3344 | $4.5442 | +172.18% |
| March, 2028 | $3.0951 | $2.895 | $3.9146 | +129.27% |
| April, 2028 | $2.8155 | $2.6056 | $3.3004 | +108.56% |
| May, 2028 | $3.1262 | $2.6417 | $3.4461 | +131.57% |
| June, 2028 | $3.2267 | $2.9263 | $3.7267 | +139.02% |
| July, 2028 | $3.2472 | $3.1371 | $3.457 | +140.53% |
| August, 2028 | $2.5678 | $2.2378 | $3.3073 | +90.21% |
| September, 2028 | $2.5783 | $2.2392 | $3.048 | +90.99% |
| October, 2028 | $1.9088 | $1.6187 | $3.1286 | +41.39% |
| November, 2028 | $2.1394 | $1.8692 | $2.1994 | +58.48% |
| December, 2028 | $2.2199 | $2.0298 | $2.3783 | +64.44% |
Artelo Biosciences Inc Stock (ARTL) Price Forecast for 2029
The 2029 price forecast for Artelo Biosciences Inc Stock (ARTL) is $2.2972 on average, with a high prediction of $3.2114 and a low estimate of $1.3829. This represents an +70.16% increase from the previous price of $1.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.1606 | $2.0903 | $2.3302 | +60.04% |
| February, 2029 | $2.1109 | $2.0908 | $2.2807 | +56.37% |
| March, 2029 | $1.7615 | $1.6315 | $3.2114 | +30.48% |
| April, 2029 | $1.662 | $1.5719 | $2.012 | +23.11% |
| May, 2029 | $1.5027 | $1.3924 | $1.7327 | +11.31% |
| June, 2029 | $1.6681 | $1.3829 | $1.693 | +23.57% |
| July, 2029 | $1.6336 | $1.5136 | $1.7633 | +21.01% |
| August, 2029 | $1.6343 | $1.5939 | $1.7938 | +21.06% |
| September, 2029 | $1.7848 | $1.5546 | $1.9846 | +32.20% |
| October, 2029 | $1.7554 | $1.6351 | $1.9354 | +30.03% |
| November, 2029 | $1.5509 | $1.4859 | $1.8356 | +14.88% |
| December, 2029 | $1.50 | $1.496 | $1.6262 | +11.11% |
Artelo Biosciences Inc Stock (ARTL) Price Forecast for 2030
Artelo Biosciences Inc Stock (ARTL) is expected to reach an average price of $38.30 in 2030, with a high forecast of $75.40 and a low forecast of $1.2002. This signifies an +2,737% surge from the last price of $1.35.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.5212 | $1.2002 | $1.901 | +12.68% |
| February, 2030 | $57.25 | $1.4515 | $75.40 | +4,141% |
| March, 2030 | $45.85 | $41.66 | $60.10 | +3,297% |
| April, 2030 | $29.65 | $3.124 | $51.10 | +2,097% |
| May, 2030 | $32.83 | $26.36 | $40.60 | +2,332% |
| June, 2030 | $36.13 | $23.70 | $39.64 | +2,577% |
| July, 2030 | $42.86 | $27.56 | $43.01 | +3,075% |
| August, 2030 | $37.91 | $26.85 | $44.96 | +2,708% |
| September, 2030 | $39.48 | $3.0894 | $46.61 | +2,825% |
| October, 2030 | $23.65 | $2.6701 | $66.76 | +1,652% |
| November, 2030 | $13.07 | $1.7311 | $25.46 | +868.29% |
| December, 2030 | $12.71 | $9.5621 | $31.16 | +841.80% |
1.62%
0.15%
Cap:
|
Volume (24h):